Cantor: Relypsa Sale Makes Sense By: Benzinga via Benzinga April 07, 2016 at 15:10 PM EDT Analysts at Cantor said the potential sale of Relypsa Inc (NASDAQ: RLYP) makes sense. Earlier, Reuters reported the biopharma company ... Read More >> Related Stocks: Astrazeneca Plc ADR Macy's